Latest Draft Of Rep. Dingell’s Global Drug Safety Bill Would Exempt Small Firms From Inspection Fees
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA would have flexibility to set inspection schedules; committee may use bill to address FDA executive bonuses
You may also be interested in...
Globalization Bill Creates Fees For Generic Pre-approval Inspections
A system for assessing fees for generic drug applicants to pay for pre-approval inspections is included in the 1FDA Globalization Act introduced in the House Jan. 28
Globalization Bill Creates Fees For Generic Pre-approval Inspections
A system for assessing fees for generic drug applicants to pay for pre-approval inspections is included in the 1FDA Globalization Act introduced in the House Jan. 28
FDA Should Be Allowed To Schedule Foreign Inspections Based On Risk – CDER’s Woodcock
“Risk-based” may be code for doing the minimum because of underfunding, Rep. Dingell says.